Labiotech.eu

News and Trends 24 Aug 2015

Novartis signs $1Bn deal for GSK’s Multiple Sclerosis Antibody

Is this Novartis' next blockbuster? The Swiss company has acquired GlaxoSmithKline's (GSK) immunosuppressive antibody Ofatumumab for up to $1Bn. The new drug allows Novartis to enter the multiple sclerosis market…

August 24, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 22 Aug 2015

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we can create the best coffee from Biotech techniques? The New…

August 22, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Aug 2015

Researchers dismantle one of Bacteria’s most wicked weapons: The Molecular Crossbow

Researchers from the Institut Pasteur and the National Center for Scientific Research in Paris have elucidated the molecular structure of a crossbow-like weapon from bacteria's arsenal. Ultimately, this could help…

August 21, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 21 Aug 2015

50 000 visitors came between January 1st and today, that’s crazy !!

Hi there, I must say I was also surprised seeing this crazy number, but it's true. 50 000 visitors have been visiting Labiotech.eu since January 1st. That's so amazing! A big…

August 21, 2015 - 1 minutemin - By Philip Hemme

News and Trends 20 Aug 2015

Lundbeck dismisses 1,000 employees to stay competitive

Lundbeck's new CEO Kåre Schultz completely restructures the company to regain profitability. About 1/6th of the company's employees will have to leave for that reason. In May, former president and COO of…

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 20 Aug 2015

DNA to play an essential role in the future of Computers?

You can do terrific things with DNA - convicting a murderer, confirming the right father ... and building computers! As biomolecular computing is ever-growing, scientists from the University of East…

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Sobi gets a long-lasting grip on a rare type of Hemophilia

In the 19th century, Queen Victoria passed the Hemophilia B to diverse royal houses of Europe. Today, its characteristic heavy bleedings can be treated quite well, as Swedish Orphan Biovitrum…

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Paris is Europe’s biggest Biocluster, but nobody knows it …

Paris is well-known for being the most beautiful city in the world. But did you also know that it concentrates most of the French Biotech industry and is Europe's biggest biocluster?…

August 19, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Top 5 Biotech Books to Enjoy your Summer on the Beach

Summer is a great time to read books and get inspired for the year to come. Here's a Top 5 list of my recommendations to read before summer ends. 1. Genentech: The Beginnings…

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

New mAb-treatment Improves the Life of European Children with Neuroblastoma

The European Commission granted marketing authorisation for United Therapeutics' Unituxin for the treatment of neuroblastoma in patients aged 12 months to 17 years. In Europe, approximately 1500 patients are diagnosed with…

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

Not only Genes matter, Cellular Origin determines the Cancer Type

Cancer occurs in uncountable forms, and we are far away from understanding all the mechanisms that lead to its variety. For example, did you know that not only the mutated…

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

Fresh money for Kuros to Speed up Bone repair

Kuros Biosurgery raised CHF15 million (€13.8M) to bring its late stage bone-repairing agents to the market. A second financing round is already planned for later this year. Bones can suffer…

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Aug 2015

Pfizer uses HiFiBiO’s brand-new technology to discover unique antibodies

French biotech startup HiFiBiO announced today it has achieved a milestone in its research collaboration with American giant Pfizer to develop new antibody therapeutics. The new milestone is triggering an…

August 17, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Aug 2015

Genmab’s Bispecific Antibodies Catch Another Big Fish

Genmab, the Danish company developing the DuoBody technology platform to create and develop bispecific antibody candidates, just signed another licensing agreement with a Big Pharma company. This time, Novo Nordisk has been…

August 17, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Aug 2015

What if the Best Coffee could be obtained thanks to Biotechnologies?

French bioengineers Camille Delebecque and Sophie Deterre founded the food Start-up Afineur in New York to revolutionize coffee. [caption id="attachment_9826" align="aligncenter" width="834"] Sophie Deterre (left) and Camille Delebecque (right), founders…

August 17, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 16 Aug 2015

What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

Encouraging facts for the European Biotech ecosystem this week! Neil Woodford's mega Biotech fund is gathering new money to pour over the European companies. Definitely good news for the financing of companies…

August 16, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 15 Aug 2015

The Sky is the Limit: Novo Nordisk continues to rise

The world's leading insulin supplier, Novo Nordisk, turns in a superb performance in the first six months of 2015. Sales revenues increased, two IIIa trials were successfully completed and two…

August 15, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 14 Aug 2015

Milestone in Stem Cell Research: European Researchers grow Millimeter-Long Muscle Fibers!

Stem cell research grows and grows in Europe! For the first time ever, researchers succeded to effectively grow a large number of muscle cells derived from pluripotent stem cells! Researchers…

August 14, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 14 Aug 2015

Roche’s €382M Acquisition to Expand its Fight against Drug-Resistant Bacteria

The biggest biotech company worldwide has just become even bigger: Roche acquired the Californian GeneWEAVE BioSciences, a privately held company that developed a cool technology to diagnose drug-resistant bacteria. For the…

August 14, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 14 Aug 2015

It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund

Cash is floating into Biotech like never before, in the US as well as in Europe. And Woodford just announced he invested over 75% of the total money he raised,…

August 14, 2015 - 2 minutesmins - By Philip Hemme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Changing the Partner Discovery Game with Connect for Biotech

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!